Skip to search formSkip to main contentSkip to account menu

Renal Cell Carcinoma

Known as: Adenocarcinoma of the Kidney, Carcinoma, Renal Cell [Disease/Finding], rccs 
A carcinoma arising from the renal parenchyma. There is a strong correlation between cigarette smoking and the development of renal cell carcinoma… 
National Institutes of Health

Related topics

Related topics

49 relations
AldesleukinBlood supply aspectsCDISC SEND Tumor Findings Results TerminologyCISH gene

Broader (4)

CarcinomaKidney NeoplasmNeoplasmsRenal carcinoma

Narrower (4)

Chromophobe Renal Cell CarcinomaClear-cell metastatic renal cell carcinomaCollecting Duct Carcinoma of the KidneyThyroid Carcinoma, Papillary, With Papillary Renal Neoplasia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal‐Cell Carcinoma
BACKGROUND The combination of pembrolizumab and axitinib showed antitumor activity in a phase 1b trial involving patients with… 
Review
2010
Review
2010
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.
PURPOSE Pazopanib is an oral angiogenesis inhibitor targeting vascular endothelial growth factor receptor, platelet-derived… 
Highly Cited
2010
Highly Cited
2010
Phase 3 trial of everolimus for metastatic renal cell carcinoma
A phase 3 trial demonstrated superiority at interim analysis for everolimus over placebo in patients with metastatic renal cell… 
Highly Cited
2009
Highly Cited
2009
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
PURPOSE A randomized, phase III trial demonstrated superiority of sunitinib over interferon alfa (IFN-alpha) in progression-free… 
Highly Cited
2006
Highly Cited
2006
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.
PURPOSE Renal cell carcinoma (RCC) is characterized by loss of von Hippel Lindau tumor suppressor gene activity, resulting in… 
Highly Cited
2002
Highly Cited
2002
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.
PURPOSE To define outcome data and prognostic criteria for patients with metastatic renal cell carcinoma (RCC) treated with… 
Highly Cited
1999
Highly Cited
1999
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.
PURPOSE To identify prognostic factors and a model predictive for survival in patients with metastatic renal-cell carcinoma (RCC… 
Review
1999
Review
1999
Rising incidence of renal cell cancer in the United States.
CONTEXT Clinical surveys have revealed that incidental detection of renal cell carcinoma is rising because of increased use of… 
Highly Cited
1994
Highly Cited
1994
Mutations of the VHL tumour suppressor gene in renal carcinoma
Multiple, bilateral renal carcinomas are a frequent occurrence in von Hippel–Lindau (VHL) disease. To elucidate the aetiological… 
Highly Cited
1956
Highly Cited
1956
Renal cell carcinoma.
  • M. Karno
  • Bulletin. Tufts-New England Medical Center
  • 1956
  • Corpus ID: 150947
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License